BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 33985413)

  • 41. A Risk Score Signature Consisting of Six Immune Genes Predicts Overall Survival in Patients with Lower-Grade Gliomas.
    Wu Y; Peng Z; Gu S; Wang H; Xiang W
    Comput Math Methods Med; 2022; 2022():2558548. PubMed ID: 35186111
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A robust six-gene prognostic signature for prediction of both disease-free and overall survival in non-small cell lung cancer.
    Zuo S; Wei M; Zhang H; Chen A; Wu J; Wei J; Dong J
    J Transl Med; 2019 May; 17(1):152. PubMed ID: 31088477
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development and validation of prognostic model based on the analysis of autophagy-related genes in colon cancer.
    Wang Y; Lin K; Xu T; Wang L; Fu L; Zhang G; Ai J; Jiao Y; Zhu R; Han X; Cai H
    Aging (Albany NY); 2021 Jul; 13(14):19028-19047. PubMed ID: 34315829
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Construction of a Signature Composed of 14 Immune Genes to Judge the Prognosis and Immune Infiltration of Colon Cancer.
    Mo S; Pei Z; Dai L
    Genet Test Mol Biomarkers; 2021 Mar; 25(3):163-178. PubMed ID: 33734891
    [No Abstract]   [Full Text] [Related]  

  • 45. Identification of a six-gene signature predicting overall survival for hepatocellular carcinoma.
    Liu GM; Zeng HD; Zhang CY; Xu JW
    Cancer Cell Int; 2019; 19():138. PubMed ID: 31139015
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A novel prognostic models for identifying the risk of hepatocellular carcinoma based on epithelial-mesenchymal transition-associated genes.
    Xiong C; Wang G; Bai D
    Bioengineered; 2020 Dec; 11(1):1034-1046. PubMed ID: 32951492
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of a Twelve-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival for Medulloblastoma.
    Zhu S; Lin F; Chen Z; Jiang X; Zhang J; Yang Q; Chen Y; Wang J
    Front Genet; 2020; 11():563882. PubMed ID: 33101383
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A Novel Immune-Related lncRNA-Based Model for Survival Prediction in Clear Cell Renal Cell Carcinoma.
    Zhang Z; Tang Y; Liu Y; Zhuang H; Lin E; Xie L; Feng X; Tian K; Zeng J; Liu J; Yu Y
    J Immunol Res; 2021; 2021():9921466. PubMed ID: 34368371
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of a Liver Progenitor Cell-Related Genes Signature Predicting Overall Survival for Hepatocellular Carcinoma.
    Li X; Lin J; Pan Y; Cui P; Xia J
    Technol Cancer Res Treat; 2021; 20():15330338211041425. PubMed ID: 34866477
    [No Abstract]   [Full Text] [Related]  

  • 50. Identification of a RNA-Seq Based 8-Long Non-Coding RNA Signature Predicting Survival in Esophageal Cancer.
    Fan Q; Liu B
    Med Sci Monit; 2016 Dec; 22():5163-5172. PubMed ID: 28028307
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer.
    Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X
    BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A potential prognostic prediction model of colon adenocarcinoma with recurrence based on prognostic lncRNA signatures.
    Jin L; Li C; Liu T; Wang L
    Hum Genomics; 2020 Jun; 14(1):24. PubMed ID: 32522293
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Novel gene signatures for prognosis prediction in ovarian cancer.
    Bao M; Zhang L; Hu Y
    J Cell Mol Med; 2020 Sep; 24(17):9972-9984. PubMed ID: 32666642
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression profile analysis identifies a two-gene signature for prediction of head and neck squamous cell carcinoma patient survival.
    Xu X; Li M; Hu J; Chen Z; Yu J; Dong Y; Sun C; Han J
    J Cancer Res Ther; 2018; 14(7):1525-1534. PubMed ID: 30589034
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comprehensive analysis reveals a metabolic ten-gene signature in hepatocellular carcinoma.
    Zhu Z; Li L; Xu J; Ye W; Chen B; Zeng J; Huang Z
    PeerJ; 2020; 8():e9201. PubMed ID: 32518728
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of biomarkers associated with diagnosis and prognosis of gastroesophageal junction adenocarcinoma-a study based on integrated bioinformatics analysis in GEO and TCGA database.
    Song D; Tian J; Hu Y; Wei Y; Lu H; Wang Y; Guan Q; Zhou Y
    Medicine (Baltimore); 2020 Dec; 99(51):e23605. PubMed ID: 33371094
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A ten-gene signature-based risk assessment model predicts the prognosis of lung adenocarcinoma.
    Jiang H; Xu S; Chen C
    BMC Cancer; 2020 Aug; 20(1):782. PubMed ID: 32819300
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A 13-Immune Gene Set Signature for Prediction of Colon Cancer Prognosis.
    Lu Z; Chen J; Yan J; Liu Q; Li F; Xiong W; Lin S; Yu K; Liang J
    Comb Chem High Throughput Screen; 2021; 24(8):1205-1216. PubMed ID: 32998675
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A five lncRNA signature for prognosis prediction in hepatocellular carcinoma.
    Sun Y; Zhang F; Wang L; Song X; Jing J; Zhang F; Yu S; Liu H
    Mol Med Rep; 2019 Jun; 19(6):5237-5250. PubMed ID: 31059056
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Riskscore Model Based on Oxidative Stress-Related Genes May Facilitate the Prognosis Evaluation for Patients With Colon Cancer.
    Chu Y; Yao Y; Hu Q; Song Q
    Clin Transl Gastroenterol; 2023 Jun; 14(6):e00582. PubMed ID: 36927989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.